Greenland Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History
Greenland Capital Management LP
- $626 Billion
- Q4 2024
A detailed history of Greenland Capital Management LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Greenland Capital Management LP holds 2,000 shares of ALNY stock, worth $466,140. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,000
Previous 1,104
81.16%
Holding current value
$466,140
Previous $304 Million
55.0%
% of portfolio
0.08%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
670Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$3.87 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.97 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.23 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.62 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.02 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $28.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...